Drug:
Reaction: DERMATITIS ATOPIC
20260101 - 20261231
No. 1701 - 1800
| No. | safetyreportid |
occurcountry |
patientonsetage |
patientsex 1:M 2:F |
|---|---|---|---|---|
Adverse reaction |
||||
Drug (openfda.generic_name, medicinalproduct) |
||||
| 1701 | 26754835 |
US |
68 | 1 |
Dermatitis atopic, |
||||
DUPILUMAB, |
||||
| 1702 | 26754860 |
US |
25 | 2 |
Dermatitis atopic, Therapeutic response shortened, Pruritus, Hypersensitivity, |
||||
DUPILUMAB, |
||||
| 1703 | 26755268 |
US |
2 | |
Dermatitis atopic, |
||||
DUPILUMAB, |
||||
| 1704 | 26755270 |
US |
51 | 2 |
Seasonal allergy, Pruritus, Dermatitis atopic, |
||||
DUPILUMAB, |
||||
| 1705 | 26755275 |
US |
42 | 2 |
Dermatitis atopic, Rash, |
||||
DUPILUMAB, |
||||
| 1706 | 26755297 |
US |
2 | |
Dermatitis atopic, Intentional dose omission, |
||||
DUPILUMAB, |
||||
| 1707 | 26755299 |
US |
64 | 2 |
Dermatitis atopic, |
||||
DUPILUMAB, |
||||
| 1708 | 26755304 |
US |
1 | |
Dermatitis atopic, Pruritus, |
||||
DUPILUMAB, NEMOLIZUMAB-ILTO, |
||||
| 1709 | 26755324 |
US |
32 | 2 |
Dermatitis atopic, |
||||
DUPILUMAB, |
||||
| 1710 | 26755330 |
US |
67 | 2 |
Sleep disorder, Pruritus, Dermatitis atopic, Drug ineffective, |
||||
DUPILUMAB, |
||||
| 1711 | 26755605 |
US |
68 | 2 |
Dermatitis atopic, |
||||
DUPILUMAB, |
||||
| 1712 | 26755615 |
US |
16 | 1 |
Dermatitis atopic, |
||||
DUPILUMAB, |
||||
| 1713 | 26755630 |
US |
2 | |
Dermatitis atopic, Dry skin, Rash, |
||||
DUPILUMAB, |
||||
| 1714 | 26755642 |
US |
32 | 1 |
Dermatitis atopic, |
||||
DUPILUMAB, |
||||
| 1715 | 26755650 |
US |
41 | 2 |
Dermatitis atopic, Eyelids pruritus, Rash, |
||||
DUPILUMAB, VALSARTAN, VALSARTAN ORAL, |
||||
| 1716 | 26755934 |
US |
50 | 1 |
Rash pruritic, Insomnia, Back pain, Eye pruritus, Dermatitis atopic, |
||||
DUPILUMAB, |
||||
| 1717 | 26756232 |
US |
1 | |
Dermatitis atopic, Erythema, |
||||
DUPILUMAB, |
||||
| 1718 | 26756549 |
US |
20 | 1 |
Dermatitis atopic, Dermatitis allergic, Product dose omission issue, |
||||
DUPILUMAB, DUPILUMAB, |
||||
| 1719 | 26756572 |
US |
40 | 2 |
Headache, Hordeolum, Pruritus, Dermatitis atopic, |
||||
DUPILUMAB, |
||||
| 1720 | 26756831 |
US |
21 | 2 |
Dermatitis atopic, Product dose omission in error, Therapeutic response delayed, |
||||
DUPILUMAB, LISDEXAMFETAMINE DIMESYLATE, LEVOCETIRIZINE DIHYDROCHLORIDE, SERTRALINE HYDROCHLORIDE, |
||||
| 1721 | 26757083 |
US |
2 | |
Pruritus, Dermatitis atopic, |
||||
DUPILUMAB, |
||||
| 1722 | 26757091 |
EU |
1 | 2 |
Adenoidal hypertrophy, Breath sounds abnormal, Dermatitis allergic, Stomatitis, Gastrointestinal disorder, Dermatitis atopic, Aphthous ulcer, Wheezing, Cough, |
||||
| 1723 | 26757412 |
US |
2 | |
Lymphadenopathy, Dermatitis atopic, Erythema, Pruritus, Eye discharge, Alopecia, Insomnia, Musculoskeletal stiffness, Injection site erythema, Injection site pruritus, |
||||
DUPILUMAB, CETIRIZINE HCL, CETIRIZINE, FLUTICASONE PROPIONATE, BUDESONIDE AND FORMOTEROL FUMARATE DIHYDRATE, |
||||
| 1724 | 26747044 |
US |
1 | |
Dermatitis atopic, |
||||
DUPILUMAB, |
||||
| 1725 | 26747047 |
US |
19 | 2 |
Dermatitis atopic, Injection site vesicles, Injection site pain, |
||||
DUPILUMAB, |
||||
| 1726 | 26747065 |
US |
4 | 1 |
Dermatitis atopic, |
||||
DUPILUMAB, |
||||
| 1727 | 26747225 |
US |
70 | 2 |
Dermatitis atopic, Product use in unapproved indication, |
||||
DUPILUMAB, DUPILUMAB, |
||||
| 1728 | 26747387 |
US |
31 | 2 |
Dermatitis atopic, Rash, |
||||
DUPILUMAB, |
||||
| 1729 | 26747389 |
US |
2 | |
Sleep disorder due to a general medical condition, Dermatitis atopic, Rash, Skin discomfort, |
||||
DUPILUMAB, ALBUTEROL SULFATE, ALBUTEROL, DEXTROAMPHETAMINE, ESTRADIOL, ESTRADIOL GEL 0.1%, ESTRADIOL TRANSDERMAL, ESTRADIOL,, MONTELUKAST SODIUM, MONTELUKAST, PREDNISONE, VENLAFAXINE, VENLAFAXINE HYDROCHLORIDE, DEXTROAMPHETAMINE, |
||||
| 1730 | 26747578 |
US |
1 | |
Dermatitis atopic, Skin exfoliation, |
||||
DUPILUMAB, |
||||
| 1731 | 26747579 |
US |
36 | 2 |
Dermatitis atopic, Pruritus, Skin fissures, Dry skin, Skin exfoliation, |
||||
DUPILUMAB, |
||||
| 1732 | 26747944 |
US |
35 | 2 |
Dermatitis atopic, |
||||
DUPILUMAB, |
||||
| 1733 | 26747948 |
US |
8 | 1 |
Dermatitis atopic, Rash, |
||||
DUPILUMAB, |
||||
| 1734 | 26748172 |
US |
55 | 1 |
Pulmonary embolism, Dermatitis atopic, Therapeutic response shortened, |
||||
DUPILUMAB, ACETAMINOPHEN, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE, ACETAMINOPHEN, ACETAMINOPHEN, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, BENZONATATE, ONDANSETRON HYDROCHLORIDE, FAMOTIDINE, |
||||
| 1735 | 26748174 |
US |
61 | 1 |
Dermatitis atopic, |
||||
DUPILUMAB, |
||||
| 1736 | 26748183 |
US |
52 | 1 |
Dermatitis atopic, Xerosis, Product use in unapproved indication, |
||||
DUPILUMAB, DUPILUMAB, MIRTAZAPINE, |
||||
| 1737 | 26748394 |
US |
2 | |
Cutaneous T-cell lymphoma, Condition aggravated, Emotional distress, Pain, Dermatitis atopic, |
||||
DUPILUMAB, DUPILUMAB, |
||||
| 1738 | 26748399 |
US |
44 | 2 |
Dermatitis atopic, |
||||
DUPILUMAB, |
||||
| 1739 | 26748687 |
US |
15 | 2 |
Dermatitis atopic, Product dose omission in error, |
||||
DUPILUMAB, DUPILUMAB, DUPILUMAB, |
||||
| 1740 | 26748695 |
US |
52 | 2 |
Dermatitis atopic, Pruritus, Rash, |
||||
DUPILUMAB, |
||||
| 1741 | 26749024 |
US |
80 | 2 |
Dermatitis atopic, |
||||
DUPILUMAB, |
||||
| 1742 | 26749065 |
US |
51 | 1 |
Dermatitis atopic, Inappropriate schedule of product administration, |
||||
DUPILUMAB, |
||||
| 1743 | 26749072 |
US |
53 | 2 |
Dermatitis contact, Dermatitis atopic, |
||||
DUPILUMAB, |
||||
| 1744 | 26749529 |
US |
53 | 2 |
Dermatitis atopic, Product dose omission issue, |
||||
DUPILUMAB, |
||||
| 1745 | 26749566 |
US |
43 | 2 |
Dermatitis atopic, |
||||
DUPILUMAB, |
||||
| 1746 | 26749572 |
US |
25 | 1 |
Dermatitis atopic, Therapeutic response shortened, |
||||
DUPILUMAB, |
||||
| 1747 | 26749946 |
US |
1 | |
Dermatitis atopic, |
||||
DUPILUMAB, |
||||
| 1748 | 26749956 |
US |
59 | 2 |
Dermatitis atopic, |
||||
DUPILUMAB, |
||||
| 1749 | 26749982 |
US |
39 | 1 |
Rash erythematous, Pruritus, Dermatitis atopic, |
||||
DUPILUMAB, |
||||
| 1750 | 26750276 |
US |
40 | 1 |
Dermatitis atopic, |
||||
DUPILUMAB, |
||||
| 1751 | 26750279 |
US |
67 | 2 |
Dermatitis atopic, Dry skin, Pruritus, |
||||
DUPILUMAB, RUXOLITINIB, ORAL SEMAGLUTIDE, VALACYCLOVIR, VALACYCLOVIR HYDROCHLORIDE, LEVOTHYROXINE SODIUM, EZETIMIBE, POTASSIUM CHLORIDE, POTASSIUM CHLORIDE EXTENDED-RELEASE, POTASSIUM CHLORIDE, DEXTROSE MONOHYDRATE, POTASSIUM CHLORIDE ORAL, OMEPRAZOLE, OMEPRAZOLE MAGNESIUM, LEBRIKIZUMAB-LBKZ, GABAPENTIN, ESTRADIOL, ESTRADIOL GEL 0.1%, ESTRADIOL TRANSDERMAL, ESTRADIOL,, EVOLOCUMAB, LISINOPRIL, |
||||
| 1752 | 26750303 |
US |
1 | 1 |
Dermatitis atopic, |
||||
DUPILUMAB, |
||||
| 1753 | 26750304 |
US |
11 | 2 |
Dermatitis atopic, |
||||
DUPILUMAB, |
||||
| 1754 | 26750305 |
US |
73 | 2 |
Dermatitis atopic, Pruritus, Erythema, |
||||
DUPILUMAB, DUPILUMAB, |
||||
| 1755 | 26750543 |
US |
69 | 2 |
Dermatitis atopic, Rash, |
||||
DUPILUMAB, DALFAMPRIDINE, |
||||
| 1756 | 26750547 |
US |
6 | 2 |
Dermatitis atopic, Erythema, |
||||
DUPILUMAB, |
||||
| 1757 | 26750919 |
US |
60 | 1 |
Dermatitis atopic, Pruritus, Paraesthesia, Conjunctivitis, |
||||
DUPILUMAB, |
||||
| 1758 | 26751150 |
US |
33 | 1 |
Dermatitis atopic, |
||||
DUPILUMAB, |
||||
| 1759 | 26751157 |
US |
35 | 2 |
Dermatitis atopic, |
||||
DUPILUMAB, |
||||
| 1760 | 26751165 |
US |
58 | 1 |
Dermatitis atopic, Rash, Discomfort, |
||||
DUPILUMAB, MOMETASONE FUROATE AND FORMOTEROL FUMARATE DIHYDRATE, FLUTICASONE PROPIONATE, FLUOCINONIDE, FLUOCINONIDE TOPICAL SOLUTION USP, 0.05%, MONTELUKAST SODIUM, CETIRIZINE HYDROCHLORIDE, |
||||
| 1761 | 26751418 |
US |
2 | |
Dermatitis atopic, |
||||
DUPILUMAB, |
||||
| 1762 | 26751428 |
US |
29 | 1 |
Dermatitis atopic, |
||||
DUPILUMAB, TACROLIMUS, TACROLIMUS OINTMENT 0.1%, TACROLIMUS EXTENDED-RELEASE CAPSULES, |
||||
| 1763 | 26751440 |
US |
48 | 2 |
Eczema, Incorrect dose administered, Insomnia, Anxiety, Product use in unapproved indication, Dermatitis atopic, Nasal congestion, Pleural effusion, Acne, Arthralgia, Pain, Respiratory symptom, Frustration tolerance decreased, Migraine, Skin fissures, Dermatitis, Back pain, Dry skin, Inflammation, Nasopharyngitis, Fall, Rash, Product dose omission in error, Dry skin, Pruritus, Accidental exposure to product, Exposure via skin contact, |
||||
DUPILUMAB, DUPILUMAB, DUPILUMAB, DOXYCYCLINE HYCLATE, DOXYCYCLINE, DOXYCLYCLINE HYCLATE, OXYCODONE, PREDNISONE, ERYTHROMYCIN, HYDROCORTISONE, ANTIPRURITIC (ANTI-ITCH), ANTI-ITCH CREAM, HYDROCORTISONE CREAM, HYDROCORTISONE 1%, HYDROCORTISONE CREAM 1%, HYDROCORTISONE CREAM 1/2%, ANTI-PRURITIC, HYDROCORTISONE CONTINUOUS SPRAY, HYDROCORTISONE LOTION, HYDROCORTISONE ACETATE, ANTI-ITCH, COOL RELIEF GEL WITH ALOE, HYDROCORTISONE SPRAY, DRS. HYDROCORTISONE, NITROFURANTOIN (MONOHYDRATE/MACROCRYSTALS), NITROFURANTOIN MONOHYDRATE/MACROCRYSTALS, LIDOCAINE, LIDOCAINE HYDROCHLORIDE, BURN RELIEF, LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE BITARTRATE, LIDICAINE, LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE, LIDOCAINE 4%, LIDOCAINE, MENTHOL, OXYCODONE HYDROCHLORIDE, OXYCODONE, PREDNISONE, DIAZEPAM, DIAZEPAM ORAL, DIAZEPAM ORAL SOLUTION (CONCENTRATE), DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, PREDNISONE, BENZONATATE, OXYCODONE AND ACETAMINOPHEN, OXYCODONE HYDROCHLORIDE AND ACETAMINOPHEN, OXYCODONE AND ACETAMINOPHEN TABLETS, OXYCODONE AND ACETAMINOPHEN, OXYCODONE HYDROCHLORIDE AND ACETAMINOPHEN, OXYCODONE AND ACETAMINOPHEN TABLETS, OXYCODONE AND ACETAMINOPHEN, OXYCODONE HYDROCHLORIDE AND ACETAMINOPHEN, OXYCODONE AND ACETAMINOPHEN TABLETS, TIZANIDINE, TIZANIDINE, FLUCONAZOLE, IBUPROFEN, IBUPROFEN CAPSULES 200 MG, IBUPROFEN TABLETS USP, 200MG, IBUPROFEN TABLET, FILM COATED, IBUPROFEN ORAL, IBUPROFEN 200MG, IBUPFROFEN, IBUPROFEN TABLET, FILM-COATED, IBUPROFEN 200 MG, IBUPROFEN CAPSULE, METHYLPREDNISOLONE, ALBUTEROL SULFATE, ALBUTEROL SULFATE, ALBUTEROL SULFATE, IBUPROFEN, IBUPROFEN CAPSULES 200 MG, IBUPROFEN TABLETS USP, 200MG, IBUPROFEN TABLET, FILM COATED, IBUPROFEN ORAL, IBUPROFEN 200MG, IBUPFROFEN, IBUPROFEN TABLET, FILM-COATED, IBUPROFEN 200 MG, IBUPROFEN CAPSULE, PREDNISONE, PREGABALIN, ESTRADIOL, ESTRADIOL GEL 0.1%, ESTRADIOL TRANSDERMAL, ESTRADIOL,, LIDOCAINE, LIDOCAINE HYDROCHLORIDE, BURN RELIEF, LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE BITARTRATE, LIDICAINE, LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE, LIDOCAINE 4%, LIDOCAINE, MENTHOL, DIAZEPAM, DIAZEPAM ORAL, DIAZEPAM ORAL SOLUTION (CONCENTRATE), PREGABALIN, BENZONATATE, CYCLOBENZAPRINE, CYCLOBENZAPRINE, CYCLOBENZAPRINE, |
||||
| 1764 | 26751583 |
US |
2 | |
Pain in extremity, Dermatitis atopic, |
||||
DUPILUMAB, |
||||
| 1765 | 26751591 |
US |
70 | 2 |
Injection site pain, Dermatitis atopic, Intentional dose omission, |
||||
DUPILUMAB, DUPILUMAB, |
||||
| 1766 | 26751732 |
US |
30 | 2 |
Dermatitis atopic, Product dose omission issue, |
||||
DUPILUMAB, |
||||
| 1767 | 26751739 |
US |
2 | |
Dermatitis atopic, Inappropriate schedule of product administration, Pruritus, |
||||
DUPILUMAB, |
||||
| 1768 | 26751864 |
US |
26 | |
Dermatitis atopic, Dry skin, Skin hyperpigmentation, |
||||
NEMOLIZUMAB-ILTO, |
||||
| 1769 | 26751921 |
US |
62 | 2 |
Dermatitis atopic, |
||||
DUPILUMAB, |
||||
| 1770 | 26741358 |
US |
63 | 2 |
Dermatitis atopic, Therapeutic response shortened, |
||||
DUPILUMAB, |
||||
| 1771 | 26741560 |
US |
22 | 2 |
Dermatitis atopic, Rash, Erythema, |
||||
DUPILUMAB, |
||||
| 1772 | 26741773 |
US |
12 | 1 |
Dermatitis atopic, Rash, |
||||
DUPILUMAB, |
||||
| 1773 | 26741797 |
US |
60 | 2 |
Knee arthroplasty, Weight increased, Dermatitis atopic, |
||||
DUPILUMAB, |
||||
| 1774 | 26741824 |
US |
42 | 2 |
Dermatitis atopic, Pruritus, |
||||
DUPILUMAB, DUPILUMAB, CLONAZEPAM, DULOXETINE HYDROCHLORIDE, DULOXETINE, BUTALBITAL, ACETAMINOPHEN, AND CAFFEINE, SUMATRIPTAN, LISINOPRIL, RIZATRIPTAN BENZOATE, PANTOPRAZOLE, SPIRONOLACTONE, TIZANIDINE HYDROCHLORIDE, UBROGEPANT, |
||||
| 1775 | 26742089 |
US |
13 | 2 |
Dermatitis atopic, |
||||
DUPILUMAB, MOMETASONE FUROATE, MOMETASONE, TRIAMCINOLONE ACETONIDE, TRIAMCINOLONE ACETONIDE OINTMENT USP, 0.05%, CETIRIZINE HYDROCHLORIDE, |
||||
| 1776 | 26742098 |
US |
70 | 1 |
Dermatitis atopic, Pruritus, Sleep disorder due to a general medical condition, |
||||
DUPILUMAB, |
||||
| 1777 | 26742129 |
US |
2 | |
Dermatitis atopic, Inappropriate schedule of product administration, |
||||
DUPILUMAB, CLONAZEPAM, DEXLANSOPRAZOLE, LAMOTRIGINE, LAMOTRIGINE EXTENDED-RELEASE, LAMOTRIGINE CHEWABLE DISPERSIBLE, LAMOTIRIGINE, NORGESTIMATE AND ETHINYL ESTRADIOL, MONTELUKAST SODIUM, MONTELUKAST, PROPRANOLOL HYDROCHLORIDE, SPIRONOLACTONE, CETIRIZINE HYDROCHLORIDE, |
||||
| 1778 | 26742345 |
US |
2 | |
Dermatitis atopic, |
||||
DUPILUMAB, PREDNISONE, |
||||
| 1779 | 26742361 |
US |
1 | |
Dermatitis atopic, Intentional dose omission, |
||||
DUPILUMAB, |
||||
| 1780 | 26742593 |
US |
1 | |
Dermatitis atopic, Therapeutic response decreased, Off label use, |
||||
DUPILUMAB, DUPILUMAB, DELGOCITINIB, TRIAMCINOLONE ACETONIDE, TRIAMCINOLONE ACETONIDE OINTMENT USP, 0.05%, |
||||
| 1781 | 26742635 |
US |
16 | 2 |
Dermatitis atopic, Inappropriate schedule of product administration, |
||||
DUPILUMAB, TRIAMCINOLONE ACETONIDE, TRIAMCINOLONE ACETONIDE OINTMENT USP, 0.05%, |
||||
| 1782 | 26742881 |
US |
35 | 2 |
Dysgeusia, Dermatitis atopic, |
||||
DUPILUMAB, DUPILUMAB, |
||||
| 1783 | 26742882 |
US |
1 | |
Dermatitis atopic, Injection site pain, |
||||
DUPILUMAB, |
||||
| 1784 | 26742899 |
US |
40 | 2 |
Dermatitis atopic, Inappropriate schedule of product administration, |
||||
DUPILUMAB, |
||||
| 1785 | 26742932 |
US |
2 | |
Dermatitis atopic, |
||||
DUPILUMAB, DUPILUMAB, DUPILUMAB, |
||||
| 1786 | 26742960 |
US |
32 | 2 |
Dermatitis atopic, |
||||
DUPILUMAB, |
||||
| 1787 | 26743266 |
US |
2 | |
Rash erythematous, Dermatitis atopic, |
||||
DUPILUMAB, DUPILUMAB, |
||||
| 1788 | 26743297 |
US |
2 | |
Dermatitis atopic, Erythema, |
||||
DUPILUMAB, |
||||
| 1789 | 26743655 |
US |
29 | 2 |
Dermatitis atopic, Off label use, |
||||
DUPILUMAB, DUPILUMAB, DUPILUMAB, |
||||
| 1790 | 26743667 |
US |
72 | 2 |
Cataract, Dandruff, Stress, Dermatitis atopic, |
||||
DUPILUMAB, CETIRIZINE HCL, CETIRIZINE, CLOBETASOL PROPIONATE, CLOBETASOL PROPIONATE OINTMENT USP, 0.05%, DILTIAZEM HYDROCHLORIDE, DILTIAZEM HYDROCHLORIDE EXTENDED-RELEASE TABLETS, FLUTICASONE PROPIONATE, FLUTICASONE PROPIONATE NASAL, LISINOPRIL, PRAVASTATIN SODIUM, PANTOPRAZOLE SODIUM, ERGOCALCIFEROL, |
||||
| 1791 | 26743673 |
US |
2 | |
Dermatitis atopic, Off label use, |
||||
DUPILUMAB, DUPILUMAB, |
||||
| 1792 | 26743677 |
US |
2 | |
Dermatitis atopic, Arthralgia, |
||||
DUPILUMAB, |
||||
| 1793 | 26743691 |
US |
48 | 2 |
Dermatitis atopic, Product dose omission in error, |
||||
DUPILUMAB, |
||||
| 1794 | 26743694 |
US |
23 | 1 |
Dermatitis atopic, Rash erythematous, Skin exfoliation, Pruritus, |
||||
DUPILUMAB, |
||||
| 1795 | 26743697 |
US |
2 | |
Dermatitis atopic, |
||||
DUPILUMAB, |
||||
| 1796 | 26743733 |
US |
52 | 2 |
Dyshidrotic eczema, Dermatitis atopic, |
||||
DUPILUMAB, DUPILUMAB, |
||||
| 1797 | 26743734 |
US |
50 | 2 |
Dermatitis atopic, |
||||
DUPILUMAB, |
||||
| 1798 | 26743735 |
US |
6 | 2 |
Dermatitis atopic, |
||||
DUPILUMAB, |
||||
| 1799 | 26744122 |
US |
9 | 2 |
Dermatitis atopic, Product dose omission issue, |
||||
DUPILUMAB, |
||||
| 1800 | 26744132 |
US |
19 | 2 |
Dermatitis atopic, Intentional dose omission, |
||||
DUPILUMAB, |
||||
disclaimer
Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.
terms
license
last_updated
2026-07-30